Sorry just saw the fast track query, my take was it would be a pivotal study on prior failures of IO therapy if they went that route. I would need to go back to the preso but it was discussed on the 2/7 or 3/7 chart. They would need more patients to show the impact I believe.
They talked about safety but didn't over stress the point this year. The data point I think I remember was nothing worse than what Keytruda or yervoy saw on its own.
Another disclaimer my memory is rubbish.
Sorry just saw the fast track query, my take was it would be a...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)